BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 18, 2018
View Archived Issues
Tumors, T cells, TFs
Read More
DWORF binding dwarfs PLN, helps failing hearts
Read More
"Typical" screening method yields novel antifungal drug class
Read More
Cytokinetics announces new cardiovascular candidates and updates pipeline progress
Read More
Increased risk of migraine in African-American children carrying common variants at 5q33.1
Read More
Positive data announced from second phase I study of intranasal betahistine
Read More
Podocalyxin as a promising new biomarker in women with polycystic ovary syndrome
Read More
Urocortin 3 is involved in the pathophysiology of diabetes
Read More
ONO-2910640 shows antidepressant-like effect in animal models of depression
Read More
PDT with exendin-IRDye700DX slows tumor growth in GLP-1R-positive tumor models
Read More
GeNeuro gives update on pHERV-K antibody program for ALS
Read More
Transgene initiates phase I/II trial of TG-6002 in advanced gastrointestinal tumors
Read More
Hutchison China MediTech initiates phase I study in China with HMPL-523 for AML
Read More
Aslan begins phase I study of ASLAN-004 for atopic dermatitis
Read More
Merck & Co. discovers antimycobacterial oxazolidinones
Read More
Beijing Jacobio Pharmaceuticals, Jacobio-Alpha Pharmaceuticals patent PTP2C inhibitors
Read More
Pseudolysin inhibitors presented by Antabio SAS
Read More
Novartis discloses protein atonal homolog 1 activators
Read More
New 5-HT2C receptor agonists described by AbbVie
Read More
Bristol-Myers Squibb discovers PD-1/PD-L1 interaction inhibitors
Read More
Eiger reports phase II data on pegylated interferon lambda in HDV infection
Read More
MeiraGTx and Janssen enter gene therapy research collaboration and evaluation agreement
Read More
GenSight reports 72-week data from REVERSE phase III trial of GS-010 in LHON
Read More
Proteostasis updates status of doublet and triplet cystic fibrosis programs
Read More
Phase II study of rozanolixizumab achieves proof of concept in myasthenia gravis
Read More
Enanta initiates phase IIa study of EDP-938 in RSV challenge model
Read More